Share Price and Basic Stock Data
Last Updated: November 28, 2025, 11:20 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Globe Commercials Ltd operates within the trading and distribution industry, with a current share price of ₹22.9 and a market capitalization of ₹13.7 Cr. The company has exhibited a consistent upward trajectory in sales, reporting ₹35.26 Cr in June 2023, which increased to ₹35.98 Cr in September 2023, and further surged to ₹49.86 Cr by March 2024. This strong revenue growth continued with remarkable figures of ₹177.81 Cr and ₹176.55 Cr in June and September 2024, respectively. The operating profit margin (OPM) also demonstrated improvement, rising from 2.44% in June 2023 to 3.17% by September 2024. This indicates not only increasing sales but also better management of expenses, which stood at ₹34.40 Cr in June 2023 and reached ₹170.95 Cr by September 2024. The company’s ability to enhance sales while controlling costs illustrates a robust operational framework, positioning it favorably within the competitive landscape of the trading sector.
Profitability and Efficiency Metrics
Globe Commercials Ltd reported a net profit of ₹3 Cr for the financial year ending March 2024, translating to an earnings per share (EPS) of ₹5.08. The net profit margin stood at 1.88%, reflecting effective cost management. The operating profit recorded for March 2024 was ₹4 Cr, with an operating profit margin of 3%. The company’s return on equity (ROE) was reported at 7.30%, while the return on capital employed (ROCE) was notably higher at 10.1%. These metrics illustrate that Globe Commercials is not only generating profits but is also utilizing its equity and capital efficiently. The cash conversion cycle (CCC) is reported at 14 days, indicating a swift turnover of assets into cash, which is advantageous for maintaining liquidity. However, the debtor days of 109 suggest potential challenges in receivables management, which could impact cash flow if not addressed.
Balance Sheet Strength and Financial Ratios
The balance sheet of Globe Commercials Ltd reflects a stable financial structure, characterized by a price-to-book value (P/BV) ratio of 1.32x. The company has no reported borrowings, indicating a debt-free status which significantly mitigates financial risk. The current ratio stands at 1.14, suggesting adequate short-term liquidity to cover liabilities. Furthermore, the long-term debt to equity ratio is reported at 0.11, reinforcing the company’s conservative approach towards leveraging. As of March 2024, the enterprise value was ₹17.93 Cr, with an EV to EBITDA ratio of 4.29, suggesting an attractive valuation relative to earnings before interest, taxes, depreciation, and amortization. The operational efficiencies are supported by a net profit margin of 1.88% and a return on assets (ROA) of 5.23%, indicating effective asset utilization in generating profits.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Globe Commercials Ltd reveals that promoters hold 8.33% of the total shares, while the public holds a significant 91.67%. The number of shareholders has grown substantially, increasing from 1,692 in June 2023 to 5,980 by September 2025, indicating rising investor interest and confidence in the company’s prospects. This broad public ownership could be indicative of a strong retail investor base, which might contribute to stability in share price movements. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) could reflect a certain level of caution among institutional players regarding the company’s growth trajectory. The dividend payout ratio was reported at 0%, indicating that profits are being reinvested into the business rather than distributed, which could appeal to growth-focused investors.
Outlook, Risks, and Final Insight
Looking forward, Globe Commercials Ltd displays a promising growth trajectory, bolstered by rising sales and improving profit margins. However, the high debtor days pose a risk to liquidity, potentially impacting cash flow if collection processes are not optimized. Additionally, while the absence of debt is a strength, it may limit the company’s ability to leverage growth opportunities through borrowing. The increasing number of shareholders reflects growing confidence, yet the lack of institutional investment could present challenges in terms of stock volatility. Overall, the company is positioned well for future growth, provided it addresses its receivables management to enhance liquidity. If Globe Commercials can maintain its operational efficiencies and improve its collection processes, it stands to benefit significantly in the competitive trading landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Globe Commercials Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 64.8 Cr. | 3.38 | 5.59/3.20 | 43.2 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Modella Woollens Ltd | 6.28 Cr. | 69.0 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 104 Cr. | 50.6 | 54.5/10.2 | 115 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 107 Cr. | 96.0 | 174/84.4 | 15.1 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Muller and Phipps (India) Ltd | 15.0 Cr. | 240 | 548/208 | 188 | 22.9 | 0.00 % | % | % | 10.0 |
| Industry Average | 10,638.20 Cr | 163.27 | 90.53 | 122.49 | 0.40% | 15.57% | 8.99% | 7.71 |
Quarterly Result
| Metric | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| Sales | 35.26 | 35.98 | 49.86 | 177.81 | 176.55 |
| Expenses | 34.40 | 35.08 | 48.44 | 172.40 | 170.95 |
| Operating Profit | 0.86 | 0.90 | 1.42 | 5.41 | 5.60 |
| OPM % | 2.44% | 2.50% | 2.85% | 3.04% | 3.17% |
| Other Income | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.86 | 0.90 | 1.46 | 5.41 | 5.60 |
| Tax % | 25.58% | 27.78% | 27.40% | 26.06% | 26.07% |
| Net Profit | 0.64 | 0.65 | 1.05 | 4.00 | 4.14 |
| EPS in Rs | 1.07 | 1.08 | 1.75 | 6.66 | 6.90 |
Last Updated: January 5, 2025, 8:02 am
Below is a detailed analysis of the quarterly data for Globe Commercials Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Sales, as of Sep 2024, the value is 176.55 Cr.. The value appears to be declining and may need further review. It has decreased from 177.81 Cr. (Jun 2024) to 176.55 Cr., marking a decrease of 1.26 Cr..
- For Expenses, as of Sep 2024, the value is 170.95 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 172.40 Cr. (Jun 2024) to 170.95 Cr., marking a decrease of 1.45 Cr..
- For Operating Profit, as of Sep 2024, the value is 5.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Jun 2024) to 5.60 Cr., marking an increase of 0.19 Cr..
- For OPM %, as of Sep 2024, the value is 3.17%. The value appears strong and on an upward trend. It has increased from 3.04% (Jun 2024) to 3.17%, marking an increase of 0.13%.
- For Other Income, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Interest, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2024, the value is 5.60 Cr.. The value appears strong and on an upward trend. It has increased from 5.41 Cr. (Jun 2024) to 5.60 Cr., marking an increase of 0.19 Cr..
- For Tax %, as of Sep 2024, the value is 26.07%. The value appears to be increasing, which may not be favorable. It has increased from 26.06% (Jun 2024) to 26.07%, marking an increase of 0.01%.
- For Net Profit, as of Sep 2024, the value is 4.14 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Jun 2024) to 4.14 Cr., marking an increase of 0.14 Cr..
- For EPS in Rs, as of Sep 2024, the value is 6.90. The value appears strong and on an upward trend. It has increased from 6.66 (Jun 2024) to 6.90, marking an increase of 0.24.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
| Metric | Mar 2024 |
|---|---|
| Sales | 162 |
| Expenses | 158 |
| Operating Profit | 4 |
| OPM % | 3% |
| Other Income | 0 |
| Interest | 0 |
| Depreciation | 0 |
| Profit before tax | 4 |
| Tax % | 27% |
| Net Profit | 3 |
| EPS in Rs | 5.08 |
| Dividend Payout % | 0% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 79% |
| 1 Year: | 3% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 3:36 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2024 | Mar 2025 |
|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2024 |
|---|---|
| Debtor Days | 109 |
| Inventory Days | 4 |
| Days Payable | 100 |
| Cash Conversion Cycle | 14 |
| Working Capital Days | 14 |
| ROCE % |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 24 |
|---|---|
| FaceValue | 10.00 |
| Basic EPS (Rs.) | 5.09 |
| Diluted EPS (Rs.) | 5.09 |
| Cash EPS (Rs.) | 5.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.83 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.83 |
| Revenue From Operations / Share (Rs.) | 270.52 |
| PBDIT / Share (Rs.) | 6.97 |
| PBIT / Share (Rs.) | 6.97 |
| PBT / Share (Rs.) | 6.97 |
| Net Profit / Share (Rs.) | 5.09 |
| NP After MI And SOA / Share (Rs.) | 5.09 |
| PBDIT Margin (%) | 2.57 |
| PBIT Margin (%) | 2.57 |
| PBT Margin (%) | 2.57 |
| Net Profit Margin (%) | 1.88 |
| NP After MI And SOA Margin (%) | 1.88 |
| Return on Networth / Equity (%) | 24.43 |
| Return on Capital Employeed (%) | 29.94 |
| Return On Assets (%) | 5.23 |
| Long Term Debt / Equity (X) | 0.11 |
| Total Debt / Equity (X) | 0.11 |
| Current Ratio (X) | 1.14 |
| Quick Ratio (X) | 1.10 |
| Enterprise Value (Cr.) | 17.93 |
| EV / Net Operating Revenue (X) | 0.11 |
| EV / EBITDA (X) | 4.29 |
| MarketCap / Net Operating Revenue (X) | 0.10 |
| Price / BV (X) | 1.32 |
| Price / Net Operating Revenue (X) | 0.10 |
| EarningsYield | 0.18 |
After reviewing the key financial ratios for Globe Commercials Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. No previous period data is available for comparison.
- For Basic EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Diluted EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Cash EPS (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 20.83. No previous period data is available for comparison.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 20.83. No previous period data is available for comparison.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 270.52. No previous period data is available for comparison.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For PBIT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For PBT / Share (Rs.), as of Mar 24, the value is 6.97. This value is within the healthy range. No previous period data is available for comparison.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 5.09. This value is within the healthy range. No previous period data is available for comparison.
- For PBDIT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBIT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For PBT Margin (%), as of Mar 24, the value is 2.57. This value is below the healthy minimum of 10. No previous period data is available for comparison.
- For Net Profit Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 8. No previous period data is available for comparison.
- For Return on Networth / Equity (%), as of Mar 24, the value is 24.43. This value is within the healthy range. No previous period data is available for comparison.
- For Return on Capital Employeed (%), as of Mar 24, the value is 29.94. This value is within the healthy range. No previous period data is available for comparison.
- For Return On Assets (%), as of Mar 24, the value is 5.23. This value is within the healthy range. No previous period data is available for comparison.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.11. This value is within the healthy range. No previous period data is available for comparison.
- For Current Ratio (X), as of Mar 24, the value is 1.14. This value is below the healthy minimum of 1.5. No previous period data is available for comparison.
- For Quick Ratio (X), as of Mar 24, the value is 1.10. This value is within the healthy range. No previous period data is available for comparison.
- For Enterprise Value (Cr.), as of Mar 24, the value is 17.93. No previous period data is available for comparison.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EV / EBITDA (X), as of Mar 24, the value is 4.29. This value is below the healthy minimum of 5. No previous period data is available for comparison.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For Price / BV (X), as of Mar 24, the value is 1.32. This value is within the healthy range. No previous period data is available for comparison.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. No previous period data is available for comparison.
- For EarningsYield, as of Mar 24, the value is 0.18. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Globe Commercials Ltd:
- Net Profit Margin: 1.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.94% (Industry Average ROCE: 15.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.43% (Industry Average ROE: 8.99%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0.48 (Industry average Stock P/E: 90.53)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.11
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.88%